This achievement represents the acquisition of the five fundamental authorizations in the industry: cultivation, manufacturing, import, export, and most recently, wholesale distribution. This complete vertical integration reinforces our commitment to providing comprehensive solutions for partners and patients worldwide.
This strategic evolution allows Cannprisma to:
- Control the entire supply chain from cultivation to final distribution
- Offer more competitive pricing in the market
- Ensure continuous product availability
- Expand our EU-GMP product portfolio through strategic partnerships
- Provide faster and more efficient delivery solutions
For our partners and clients, this advancement translates to:
- Reduced operational costs
- Enhanced supply chain reliability
- Broader access to EU-GMP products
- Simplified procurement process
- Direct quality assurance from seed to delivery
As a European reference hub for medical cannabis, Cannprisma is now uniquely positioned to provide complete solutions with unmatched efficiency and value.
We invite all interested parties to explore how our enhanced capabilities can support your business growth.
